Aegerion Pharmaceuticals Inc (AEGR)

HEALTH CARE: HEALTH CARE
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

ONE MAIN STREET CAMBRIDGE, MA 02142

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of life-altering therapeutics for rare and often fatal genetic lipid disorders. Its lead product in Phase III clinical development, lomitapide, is a small molecule, oral therapy to treat severe lipid disorders for an orphan patient population. Lomitapide has demonstrated the lowering of both bad cholesterol (LDL-C) and triglyceride (TG) levels in patients with a rare form of hypercholesterolemia. The company plans to initiate a clinical program to treat patients with a severe genetic form of hypertriglyceridemia called familial chylomicronemia (FC).

View SEC Filings from AEGR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 0 0 (0.0%) (0.0%)
13F shares: 0 0
% Ownership
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AEGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AEGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOTTO ANTONIO M JR MD D PHIL

  • Director
No longer subject to file 2016-11-29 0

SCHEER DAVID

  • Director
No longer subject to file 2016-11-29 0

BARER SOL J

  • Director
No longer subject to file 2016-11-29 0

THOMAS PAUL

  • Director
No longer subject to file 2016-11-29 0

SMITH SANDFORD D

  • Director
No longer subject to file 2016-11-29 0

VANLENT ANNE

  • Director
No longer subject to file 2016-11-29 0

PLUTZKY JORGE MD

  • Director
No longer subject to file 2016-11-29 0

PERRY GREGORY D

  • SEE REMARKS
No longer subject to file 2016-11-29 0

STERN DONALD K

  • Director
No longer subject to file 2016-11-29 0

HARSHBARGER BENJAMIN GENERAL COUNSEL AND SECRETARY

  • Officer
No longer subject to file 2016-11-29 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
No longer subject to file 2016-11-29 0

LOUIS ROGER CHIEF COMPLIANCE OFFICER

  • Officer
No longer subject to file 2016-11-29 0

SZELA MARY T CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2016-11-29 0

CHAN BARBARA Y VP, CHIEF ACCOUNTING OFFICER

  • Officer
No longer subject to file 2016-11-29 0

BUONO LINDA SR. VP, HUMAN RESOURCES

  • Officer
No longer subject to file 2016-11-29 0

ORLOFF JOHN J EVP, RESEARCH AND DEVELOPMENT

  • Officer
0 2016-11-01 0

MENES REMI A GLOBAL CHIEF COMMERCIAL OFF.

  • Officer
0 2016-09-12 0

QLT INC/BC

  • 10% Owner
0 2016-06-14 0

CARTER MARTHA J. SEE REMARKS

  • Officer
0 2016-05-09 0

CURTIS ERIC PRESIDENT, U.S. COMMERCIAL

  • Officer
0 2015-08-26 0

SUMERAY MARK CHIEF MEDICAL OFFICER

  • Officer
0 2015-08-04 0

COOK ANNE MARIE SVP, GENERAL COUNSEL

  • Officer
0 2015-08-04 0

WEGER MARY CHIEF PERFORMANCE OFFICER

  • Officer
0 2015-08-04 0

ANDREWS WILLIAM T. SEE REMARKS

  • Officer
0 2015-08-04 0

AUBUCHON DAVID CHIEF FINANCIAL OFFICER

  • Officer
0 2015-06-05 0

BEER MARC D CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2015-04-01 0

FITZPATRICK MARK J. CHIEF FINANCIAL OFFICER

  • Officer
0 2015-04-01 0

FRASER CRAIG CHIEF OPERATING OFFICER

  • Officer
0 2015-04-01 0

PERCEPTIVE ADVISORS LLC

EDELMAN JOSEPH

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
No longer subject to file 2013-06-15 0

ALTA BIOPHARMA PARTNERS III LP

PENHOET EDWARD

CHAMPSI FARAH

HURWITZ EDWARD

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

KILEY ALISON

  • 10% Owner
No longer subject to file 2012-10-15 0

ROTHERA MARK GLOBAL PRESIDENT

  • Officer
0 2012-05-01 0

ADVENT INTERNATIONAL CORP/MA

  • MEMBER OF GROUP > 10%
2,457,879 2012-03-09 0

ADVENT INTERNATIONAL LLC

  • MEMBER OF GROUP > 10%
2,430,765 2012-03-09 0

AHLS III GP LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
2,430,765 2012-03-09 0

ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
985,052 2012-03-09 0

ADVENT HEALTHCARE & LIFE SCIENCES III-A LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
1,445,713 2012-03-09 0

ADVENT PARTNERS HLS III LIMITED PARTNERSHIP

  • MEMBER OF GROUP > 10%
27,114 2012-03-09 0

INDEX VENTURE ASSOCIATES III LTD

INDEX VENTURES III (DELAWARE) L.P.

INDEX VENTURES III (JERSEY) L.P.

INDEX VENTURES III PARALLEL ENTREPRENEUR FUND (JERSEY) L.P.

YUCCA PARTNERS L.P. JERSEY BRANCH

  • 10% Owner
No longer subject to file 2012-01-30 0

KILEY ALISON

  • Director
  • 10% Owner
2,690,251 2011-08-08 0

ALTA BIOPHARMA PARTNERS III LP

PENHOET EDWARD

CHAMPSI FARAH

HURWITZ EDWARD

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

  • 10% Owner
2,741,272 2011-08-08 0

OLLIER MICHELE

  • Director
  • 10% Owner
2,131,827 2011-07-29 0

TRIBBLE DIANE L. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-03-01 0

ALTA BIOPHARMA PARTNERS III LP

ALTA BIOPHARMA MANAGEMENT III LLC

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

DELEAGE JEAN

CHAMPSI FARAH

PENHOET EDWARD

HURWITZ EDWARD

  • 10% Owner
60,502 2010-10-27 0

LEWIS WILLIAM PRESIDENT, PFO AND TREASURER

  • Officer
412,761 2010-10-27 0

FISHERMAN JASON S

  • Director
7,848 2010-10-27 0

CAVAN JOHN T VP & CHIEF ACCOUNTING OFFICER

  • Officer
0 2010-10-21 0

PELLIZZARI CHRISTINE A EVP, GEN. COUNSEL & SECRETARY

  • Officer
0 2010-10-21 0

SCHEER INVESTMENT HOLDINGS VII LLC

  • DIRECTOR IS MANAGING MEMBER
640,154 2010-10-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments